What Is a Libido Pill and How Does It Work?

A libido pill is any medication or supplement marketed to increase sexual desire. The term covers a wide range of products, from FDA-approved prescription drugs that target brain chemistry to over-the-counter herbal supplements with varying levels of evidence behind them. Understanding the differences matters, because what you’ll find in a pharmacy with a prescription and what you’ll find on a supplement shelf online are fundamentally different products with different levels of safety testing.

Prescription Options for Women

Two prescription medications are currently approved in the United States specifically for low sexual desire in premenopausal women. Both target a condition formally called female sexual interest/arousal disorder, which requires symptoms lasting at least six months that cause genuine personal distress. Simply having a lower sex drive than you used to, without it bothering you, doesn’t meet the threshold for diagnosis or treatment.

The first, flibanserin (sold as Addyi), is a daily pill taken at bedtime. It works by shifting the balance of brain chemicals involved in desire. Specifically, it increases dopamine and norepinephrine activity in the prefrontal cortex, both of which play stimulating roles in sexual desire and arousal, while reducing serotonin’s inhibitory effect on those same pathways. Think of it as dialing down a brake (serotonin) while pressing the accelerator (dopamine). In clinical trials, about 21% of women taking flibanserin reported being “much improved” or “very much improved” after 24 weeks, compared to roughly 10% on placebo. That’s a modest but real benefit for some women.

Flibanserin comes with a notable restriction around alcohol. Drinking close to the time you take your dose raises the risk of dangerously low blood pressure and fainting. The current guidance: wait at least two hours after one or two drinks before taking it at bedtime, and skip your dose entirely if you’ve had three or more drinks that evening. You also shouldn’t drink alcohol until the following day after taking it.

The second option, bremelanotide (Vyleesi), is an injection you give yourself in the thigh or abdomen at least 45 minutes before anticipated sexual activity. It works through a different pathway, activating receptors in the brain that influence arousal and desire. It’s used as needed rather than daily.

Prescription Options for Men

The landscape for men looks different because the most well-known sexual health pills, like sildenafil (Viagra) and tadalafil (Cialis), treat erectile dysfunction, not low desire. These medications increase blood flow to the penis but don’t directly affect how much you want sex in the first place. A man with normal desire who struggles with erections will benefit. A man who simply has no interest in sex may not.

For men whose low desire stems from low testosterone, testosterone replacement therapy is the primary treatment. A meta-analysis covering over 1,200 men across 14 trials found that testosterone therapy significantly improved sexual desire scores. The response can be surprisingly fast: studies on testosterone gel showed that desire began increasing within two to three days of starting treatment, with significant improvements by the end of the first week. Most men reached peak benefit by week two, which held steady through at least a month.

Testosterone therapy is more effective at restoring desire than at fixing erections. It works well as a standalone treatment for men with mild erectile dysfunction, but men with moderate or severe dysfunction, often caused by diabetes, pelvic surgery, or nerve damage, typically need additional treatment because the root cause isn’t hormonal.

Off-Label Medications

Some doctors prescribe medications off-label for low libido, meaning the drug is approved for something else but happens to help with desire. The most studied of these is bupropion, an antidepressant that boosts dopamine and norepinephrine rather than serotonin. A meta-analysis of four studies found bupropion was nearly three times more likely than placebo to improve problems with sexual desire. Interestingly, lower doses appeared more effective for desire than higher ones.

Bupropion is particularly relevant for people whose low libido is a side effect of SSRI antidepressants, which are well known for dampening sexual interest. Switching to bupropion or adding it alongside an existing antidepressant are both common strategies. In a head-to-head comparison with another antidepressant class, bupropion produced significantly better sexual function scores in young women with depression.

Herbal Supplements and OTC Products

The supplement aisle is packed with products labeled as libido boosters, often containing ingredients like maca, ginseng, tribulus, ashwagandha, and L-arginine. The evidence behind them is mixed, and the quality of products varies enormously.

A meta-analysis pooling results from multiple randomized trials found that ginseng, L-arginine, and tribulus each showed statistically significant improvements in erectile function scores. L-arginine had the strongest pooled effect. Ashwagandha, despite its popularity, showed no significant difference from placebo when researchers pooled the available data on erectile performance. It’s worth noting that most of this research measured erectile function in men, not subjective desire in either sex, so calling these “libido pills” is a stretch for many of them.

The FDA has repeatedly warned that many sexual enhancement supplements sold online and in stores contain hidden pharmaceutical ingredients, including the same active compounds found in prescription erectile dysfunction drugs, at uncontrolled doses. These products are sometimes falsely marketed as “all-natural” when they actually contain potent drugs that can interact dangerously with other medications, particularly heart drugs containing nitrates. The FDA maintains an active list of tainted sexual enhancement products that it updates regularly.

How Desire Works in the Brain

Sexual desire isn’t a single switch. It emerges from a tug-of-war between brain networks that promote approach behavior and networks that promote avoidance. At least five major chemical signaling systems feed into this balance: dopamine generally drives motivation and wanting, norepinephrine fuels arousal and alertness, and serotonin tends to act as a brake on both. Acetylcholine and histamine play supporting roles.

This is why so many libido medications target the same basic idea: increase the excitatory signals (dopamine, norepinephrine) or decrease the inhibitory ones (serotonin), or both. Flibanserin does exactly this. Testosterone raises the baseline sensitivity of desire-related circuits. Bupropion tips the balance by boosting dopamine and norepinephrine without the serotonin increase that suppresses desire. The approach varies, but the neurochemical logic is consistent.

What to Realistically Expect

No libido pill creates desire out of nothing. Prescription options for women show modest average improvements, with meaningful benefit for a subset of users. The 24-week flibanserin data showed that treated women gained about one additional satisfying sexual event per month compared to placebo. That’s meaningful for some, disappointing for others.

Timelines vary by treatment. Testosterone therapy in men can produce noticeable changes in desire within the first week, with full effects stabilizing around week two. Flibanserin typically requires four to eight weeks of nightly use before you can judge whether it’s helping. On-demand options like bremelanotide work within the same session, administered before sexual activity.

For any of these treatments, the underlying cause of low desire matters enormously. Relationship problems, stress, hormonal changes from menopause or aging, medication side effects, and chronic health conditions all contribute differently. A pill that adjusts brain chemistry won’t resolve a relational issue, and a supplement won’t correct a hormonal deficiency. The most effective approach usually starts with identifying what’s actually driving the change in desire.